UK government sues Servier for £220m over alleged blocking of generic substituteBMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d3645 (Published 09 June 2011) Cite this as: BMJ 2011;342:d3645
- Clare Dyer
The UK government is suing the French drug company Servier for £220m (€246m; $360m) for allegedly blocking generic versions of its angiotensin converting enzyme inhibitor perindopril entering the UK market between 2001 and 2007.
The Department of Health, along with all the strategic health authorities and primary care trusts in England, has launched a High Court action to reclaim the money they say that the NHS in England was forced to pay for more expensive drugs.
Servier’s patent on the drug, used to treat hypertension and heart disease, ran out in 2001, after which, the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial